Danish life science foundations broke investment records in 2021
Some of Denmark’s most powerful funds, many of which have links to the pharmaceutical industry, broke one record after another in 2021. This provides opportunities, respective CEOs of the Novo Nordisk Foundation, William Demant Invest and the Lundbeck Foundation say.
by benjamin werner christiansen, translated by catherine brett
After a historically strong 2021, some of Denmark’s most powerful funds have record capital at their disposal.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
The Lundbeck Foundation delivers record-breaking result
For subscribers
.jpg&w=384&q=75)
